Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05078242 · ClinicalTrials.gov registry record · NA

Virtual Reality - Chronic Pain At-Home Pilot Study

A NA study, sponsored by Albert Einstein College of Medicine.

Completed
Registry status
NA
Development phase
6
Enrollment target

NCT05078242 is a NA study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 6 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05078242, a NA study, has completed, sponsored by Albert Einstein College of Medicine.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

This is a short pilot usability study of a virtual reality device for patients with chronic pain.

Interventions

  • DEVICE EaseVRx

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2021-11-15
Est. Completion 2022-12-31
Phase NA

Sponsor

Albert Einstein College of Medicine

175 total trials

What the Registry Record Tells You About NCT05078242

The ClinicalTrials.gov registry entry for NCT05078242 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which EaseVRx is the first listed.

NCT05078242 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05078242 about?

NCT05078242 is a clinical study titled "Virtual Reality - Chronic Pain At-Home Pilot Study". This is a short pilot usability study of a virtual reality device for patients with chronic pain.

What is the current status of trial NCT05078242?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2021-11-15. Estimated completion is 2022-12-31.

What interventions are being tested in trial NCT05078242?

The interventions under investigation include: EaseVRx (DEVICE).

Who is sponsoring clinical trial NCT05078242?

This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.